Early Stage Biotech CEO of Cytonics On Operating In A Recession, Osteoarthritis, and Career Ep.642
Dan interviews Joey Bose, CEO of Cytonics Corporation. Cytonics is a R&D company dedicated to discovering and developing therapeutics for musculoskeletal diseases based on the protease inhibitor Alpha-2-Macroglobulin (A2M).